ABT-869

点击看大图

如果您对该产品感兴趣的话,可以

产品名称: ABT-869

产品型号:

产品展商: 其它品牌

产品文档: 无相关文档

简单介绍

CAS:796967-16-3Formula:C21H18FN5OMW:375.41Appearance:CrystallineSolidPurity:99%

ABT-869 的详细介绍

ABT-869 is multi-targeted inhibitor of all members of the VEGF and PDGF receptor families (e.g., KDR, ICvalue of 4 nM), but has much less activity (ICvalues >1 M) against unrelated receptor tyrosine kinases, soluble tyrosine kinases or serine/threonine kinases. The kinase inhibition profile of ABT-869 is evident in cellular assays of RTK phosphorylation (ICvalues of 2, 4 and 7 nM for PDGFR, KDR and CSF-1R, respectively) and VEGF-stimulated proliferation (0.2 nM ICfor human endothelial cells).

Additional Information

Synonyms	Linifanib
Product #	A-2177
CAS #	796967-16-3
Chemical Name	N-[4-(3-AMINO-1H-INDAZOL-4-YL)PHENYL]-N'-(2-FLUORO-5-METHYLPHENYL)UREA
Formula	C₂₁H₁₈FN₅O
MW	375.41
Appearance	Crystalline Solid
Purity	99%
Solubility	DMSO
Melting Point	180-183 °C
Storage Temp	-20°C
Therapeutic Area	Oncological Disorders
Use	Linifanib (ABT-869) is a structurally novel, potent inhibitor of receptor tyrosine kinases (RTK), vascular endothelial growth factor (VEGF) use in cancer

Additional Information

MDL Number	MFCD11840918
ChemACX	X1671178-1
InChI	InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28)
SMILES	CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N

产品留言

标题

联系人

联系电话

内容

验证码

点击换一张

注：1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!